We apologize for Proteopedia being slow to respond. For the past two years, a new implementation of Proteopedia has been being built. Soon, it will replace this 18-year old system. All existing content will be moved to the new system at a date that will be announced here.
Phospholipase C
From Proteopedia
(Difference between revisions)
| Line 2: | Line 2: | ||
== Function == | == Function == | ||
| + | |||
| + | '''Phospholipase C''' (PLC) cleaves phospholipids before the phosphate group. | ||
| + | |||
| + | '''Phospholipase C β,γ,δ,ε''' catalyze the conversion of phosphatidylinositol 4,5-bisphosphate to inositol 1,4,5-trisphosphate and diacylglycerol.<ref>PMID:12054652</ref> | ||
'''Phosphatidylinositol-specific phospholipase C''' (PIPLC) catalyzes the hydrolysis of phosphatidylinositol into inositol triphosphate and deacylglycerol. PIPLC functions at the plasma membrane. PIPLC can release phosphatidylinositol-linked proteins (i.e., acetylcholinesterase) from the membrane by enzymatically cleaving their GPI anchor. | '''Phosphatidylinositol-specific phospholipase C''' (PIPLC) catalyzes the hydrolysis of phosphatidylinositol into inositol triphosphate and deacylglycerol. PIPLC functions at the plasma membrane. PIPLC can release phosphatidylinositol-linked proteins (i.e., acetylcholinesterase) from the membrane by enzymatically cleaving their GPI anchor. | ||
== Disease == | == Disease == | ||
| + | |||
| + | Phospholipase C γ gene blocking can stop breast cancer.<ref>PMID:19074886</ref> Phospholipase C δ has important suppressive role in the development and progression of esophageal carcinoma. | ||
== Relevance == | == Relevance == | ||
| Line 33: | Line 39: | ||
**[[1aod]] – LmPIPLC + myo-inositol <br /> | **[[1aod]] – LmPIPLC + myo-inositol <br /> | ||
**[[3ea2]] – BtPIPLC + myo-inositol <br /> | **[[3ea2]] – BtPIPLC + myo-inositol <br /> | ||
| - | **[[3v16]], [[4f2b]] – SaPIPLC + myo-inositol <br /> | + | **[[3v16]], [[4f2b]], [[4rv3]] – SaPIPLC + myo-inositol <br /> |
| - | **[[3v1h]], [[4i9t]] – SaPIPLC (mutant) + myo-inositol <br /> | + | **[[3v1h]], [[4i9t]], [[4s3g]] – SaPIPLC (mutant) + myo-inositol <br /> |
**[[4i90]] – SaPIPLC (mutant) + choline <br /> | **[[4i90]] – SaPIPLC (mutant) + choline <br /> | ||
**[[4i9j]] – SaPIPLC (mutant) + diC4PC <br /> | **[[4i9j]] – SaPIPLC (mutant) + diC4PC <br /> | ||
| + | |||
| + | * Phospholipase C β | ||
| + | |||
| + | **[[1jad]] – PLCB - turkey<br /> | ||
| + | **[[2zkm]] – hPLCB-2 - human<br /> | ||
| + | **[[2fju]] – hPLCB-2 + RAC1<br /> | ||
| + | **[[3ohm]], [[4gnk]], [[4qj3]] – hPLCB-3 + guanine nucleotide-binding protein G subunit alpha<br /> | ||
| + | **[[4qj4]], [[4qj5]] – hPLCB-3 + guanine nucleotide-binding protein G subunit alpha + inositol phosphate derivative <br /> | ||
| + | **[[3qr0]] – PLCB - cuttlefish<br /> | ||
| + | **[[3qr1]] – PLCB - squid<br /> | ||
| + | |||
| + | * Phospholipase C γ | ||
| + | |||
| + | **[[1hsq]], [[2hsp]] – hPLCG SH3 domain - NMR <br /> | ||
| + | **[[4fbn]] – hPLCG-1<br /> | ||
| + | **[[2k2j]] – hPLCG-2 split PH2 domain - NMR<br /> | ||
| + | **[[2w2w]] – hPLCG-2 split PH2 domain (mutant)<br /> | ||
| + | **[[2w2x]] – hPLCG-2 split PH2 domain + RAC2 br /> | ||
| + | **[[4ey0]] – hPLCG-1 SH2 domain (mutant)<br /> | ||
| + | **[[2pld]], [[2ple]] – PLCG C terminal SH2 domain + PDGF peptide – bovine - NMR <br /> | ||
| + | **[[1ywp]] – rPLCG-1 SH3 domain – rat<br /> | ||
| + | **[[1y0m]] – rPLCG-1 SH3 domain (mutant)<br /> | ||
| + | **[[2fjl]] – rPLCG-1 split PH2 domain - NMR<br /> | ||
| + | **[[2eob]] – rPLCG-2 SH2 domain - NMR<br /> | ||
| + | **[[1ywo]] – rPLCG-1 SH3 domain + lymphocyte cytosolic protein peptide <br /> | ||
| + | **[[4k44]], [[4k45]] – rPLCG C terminal SH2 domain <br /> | ||
| + | **[[2dx0]] – mPLCG-2 N terminal SH2 domain – mouse<br /> | ||
| + | **[[2eqi]] – mPLCG-2 SH3 domain - NMR<br /> | ||
| + | |||
| + | * Phospholipase C δ | ||
| + | |||
| + | **[[1mai]] – rPLCD-1 PH domain + inositol triphosphate <br /> | ||
| + | **[[1qas]], [[1qat]], [[1djg]], [[1djh]], [[1dji]], [[2isd]] – rPLCD-1 <br /> | ||
| + | **[[1djx]], [[1djy]] – rPLCD-1 + inositol triphosphate <br /> | ||
| + | **[[1djz]], [[1djw]] – rPLCD-1 + inositol phosphate derivative <br /> | ||
| + | |||
| + | * Phospholipase C ε | ||
| + | |||
| + | **[[2bye]] – hPLCE-1 RA1 domain - NMR <br /> | ||
| + | **[[2byf]] – hPLCE-1 RA2 domain - NMR <br /> | ||
| + | |||
| + | * Phospholipase C | ||
| + | |||
| + | **[[1ah7]] – BcPLC<br /> | ||
| + | **[[1p5x]], [[2ffz]], [[2fgn]], [[2huc]] – BcPLC (mutant)<br /> | ||
| + | **[[1p6d]], [[1p6e]] – BcPLC (mutant) + phosphocholine derivative <br /> | ||
| + | **[[1ca1]], [[1qm6]], [[1qmd]], [[1gyg]], [[1kho]], [[2wxt]] – CpPLC – Clostridium perfringensbr /> | ||
| + | **[[2wxu]], [[2wy6]] – CpPLC (mutant)<br /> | ||
| + | |||
}} | }} | ||
Revision as of 09:56, 10 January 2016
| |||||||||||
3D structures of phosphatidylinositol-specific phospholipase C
Updated on 10-January-2016
References
- ↑ Barr AJ, Marjoram R, Xu J, Snyderman R. Phospholipase C-beta 2 interacts with mitogen-activated protein kinase kinase 3. Biochem Biophys Res Commun. 2002 Apr 26;293(1):647-52. PMID:12054652 doi:http://dx.doi.org/10.1016/S0006-291X(02)00259-0
- ↑ Sala G, Dituri F, Raimondi C, Previdi S, Maffucci T, Mazzoletti M, Rossi C, Iezzi M, Lattanzio R, Piantelli M, Iacobelli S, Broggini M, Falasca M. Phospholipase Cgamma1 is required for metastasis development and progression. Cancer Res. 2008 Dec 15;68(24):10187-96. doi: 10.1158/0008-5472.CAN-08-1181. PMID:19074886 doi:http://dx.doi.org/10.1158/0008-5472.CAN-08-1181
Proteopedia Page Contributors and Editors (what is this?)
Michal Harel, Alexander Berchansky, Joel L. Sussman, Jaime Prilusky
